vaccination failure; sars-cov-2 infection; this is a spontaneous report received from a contactable reporter(s) (physician) from the regulatory authority-web. regulatory number: at-basgages-2022-015077 (ra). a 57 year-old male patient received bnt162b2 (comirnaty), intramuscular, administration date 11jun2021 (lot number: fd1921) as dose 2, single and intramuscular, administration date 30apr2021 (lot number: ey3014) as dose 1, single for covid-19 immunisation. the patient's relevant medical history was not reported. there were no concomitant medications. the following information was reported: drug ineffective (medically significant) with onset 28oct2021, outcome "unknown", described as "vaccination failure"; covid-19 (medically significant) with onset 28oct2021, outcome "unknown", described as "sars-cov-2 infection". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (28oct2021) positive, notes: variant pcr-based: b.1.617.2. variant sequenced: n.a. n501y-positive: no. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : at-pfizer inc-202200289286 same reporter, same patient, different dose of the vaccine, different event

test date: 20211028; test name: covid-19 pcr test; test result: positive ; comments: variant pcr-based: b.1.617.2 variant sequenced: n.a. n501y-positive: no

na

na